Mesenteric microvascular inflammatory responses to systemic hypoxia are mediated by PAF and LTB4

Journal of Applied Physiology

Volumn 94, Issue 6, 2003, Pages 2313-2322

  Casillan, Alfred J ^a   Gonzalez, Norberto C ^a   Johnson, Jennifer S ^a   Steiner, Dawn R S ^a   Wood, John G ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammatory mediators; Intravital microscopy; Leukocyte emigration; Leukocyte endothelial adhesive interactions; Microcirculation

Indexed keywords

APAFANT; LEUKOTRIENE B4; REACTIVE OXYGEN METABOLITE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR AFFECTING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; HYPOXIA; INFLAMMATION; MALE; MESENTERY BLOOD FLOW; MICROCIRCULATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT;

EID: 0038178074     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00047.2002     Document Type: Article

References (48)

1. Ali MH, Schlidt SA, Chandel NS, Hynes KL, Schumacker PT, and Gewertz BL. Endothelial permeability and IL-6 production during hypoxia: role of ROS in signal transduction. Am J Physiol Lung Cell Mol Physiol 277: L1057-L1065, 1999.
2. Arnould T, Michiels C, and Remacle J. Increased PMN adherence on endothelial cells after hypoxia: involvement of PAF, CD18/CD11b, and ICAM-1. Am J Physiol Cell Physiol 264: C1102-C1110, 1993.
3. Arndt H, Russell JB, Kurose I, Kubes P, and Granger DN. Mediators of leukocyte adhesion in rat mesenteric venules elicited by inhibition of nitric oxide synthesis. Gastroenterology 105: 675-680, 1993.
4. Baldwin AL, Thurston G, and Al Naemi H. Inhibition of nitric oxide synthesis increases venular permeability and alters endothelial actin cytoskeleton. Am J Physiol Heart Circ Physiol 274: H1776-H1784, 1998.
5. Banner KH, Moriggi E, Da Ros B, Schioppacassi G, Semeraro C, and Page CP. The effect of selective phosphodiesterase 3 and 4 isomerize inhibitors and established anti-asthma drugs on inflammatory cell activation. Br J Pharmacol 119: 1255-1261, 1996.
6. Beyer AJ, Smalley DM, Shyr YM, Wood JG, and Cheung LY. PAF and CD18 mediate neutrophil infiltration into the upper gastrointestinal tract during intraabdominal sepsis. Am J Physiol Gastrointest Liver Physiol 275: G467-G472, 1998.
7. 4. Clin Biochem 23: 459-468, 1990.
8. Borgquist JD, Quinn MT, and Swain SD. Adhesion to extracellular matrix proteins modulates bovine neutrophil responses to inflammatory mediators. J Leukoc Biol 71: 764-774, 2002.
9. Bouskela E and Donyo KA. Effects of oral administration of purified micronized flavonoid fraction on increased microvascular permeability induced by various agents and on ischemia/reperfusion in the hamster cheek pouch. Angiology 48: 391-399, 1997.
10. Bussolati B, Mariano F, Cignetti A, Guarini A, Cambi V, Foa R, Piccoli G, and Camussi G. Platelet-activating factor synthesized by IL-12-stimulated polymorphonuclear neutrophils and NK cells mediates chemotaxis. J Immunol 161: 1493-1500, 1998.
11. Bussolino F, Camussi G, Aglietta M, Braquet P, Bosia A, Pescarmona G, Sanavio F, D'Urso N, and Marchisio PC. Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures. J Immunol 139: 2439-2446, 1987.
12. Caplan MS, Adler L, Kelly A, and Hsueh W. Hypoxia increases stimulus-induced PAF production and release from human umbilical vein endothelial cells. Biochim Biophys Acta 1128: 205-210, 1992.
13. Chandel NS, Trzyna WC, McClintock DS, and Schumacker PT. Role of oxidants in NF-κB activation and TNF-α gene transcription induced by hypoxia and endotoxin. J Immunol 165: 1013-1021, 2000.
14. Davis MJ. Determination of volumetric flow in capillary tubes using an optical Doppler velocimeter. Microvasc Res 34: 223-230, 1987.
15. Duranteau J, Chandel NS, Kulisz A, Shao Z, and Schumacker PT. Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem 273: 11619-11624, 1998.
16. Granger DN, Grisham MB, and Kvietys PR. Mechanisms of microvascular injury. In: Physiology of the Gastrointestinal Tract (3rd ed.), edited by Johnson LR. New York: Raven, 1994, p. 1693-1722.
17. Harris NR, Whitt SP, Zilberberg J, Alexander JS, and Rumbault RE. Extravascular transport of fluorescently labeled albumins in rat mesentery. Microcirculation 9: 177-187, 2002.
18. Heller A, Koch T, Schmeck J, and van Ackern K. Lipid mediators in inflammatory disorders. Drugs 55: 487-496, 1998.
19. House SD and Lipowsky H. Leukocyte-endothelium adhesion: microdynamics in mesentery of the cat. Microvasc Res 34: 223-230, 1987.
20. The BO and Raj JU. Leukotriene metabolism by intrapulmonary vessels of newborn lambs: effect of platelet activating factor. Exp Lung Res 27: 331-348, 2001.
21. 2+ mobilization in brain microvascular endothelial cells. Am J Physiol Heart Circ Physiol 279: H2310-H2318, 2000.
22. Kurose I, Argenbright LW, Wolf R, Lianxi L, and Granger DN. Ischemia/reperfusion-induced microvascular dysfunction: role of oxidants and lipid mediators. Am J Physiol Heart Circ Physiol 272: H2976-H2982, 1997.
23. Kurose I, Wolf R, Grisham MB, Aw TY, Specian RD, and Granger DN. Microvascular responses to inhibition of nitric oxide production. Role of active oxidants. Circ Res 76: 30-39, 1995.
24. Laux V and Seiffge D. Mediator-induced changes in macromolecular permeability in the rat mesenteric microcirculation. Microvasc Res 49: 117-133, 1995.
25. Lefer AM. Significance of lipid mediators in shock states. Circ Shock 27: 3-12, 1989.
26. 2. Biochemistry 40: 14921-14931, 2001.
27. 2 in hypoxic ventricular myocytes. Am J Physiol Cell Physiol 274: C1727-C1737, 1998.
28. Metters KM. Leukotriene receptors. J Lipid Mediat Cell Signal 12: 413-427, 1995.
29. Michel CC and Curry FE. Microvascular permeability. Physiol Rev 79: 703-761, 1999.
30. Montrucchio G, Alloatti G, and Camussi G. Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev 80:1669-1699, 2000.
31. Nagase T, Ishii S, Katayama H, Fukuchi Y, Ouchi Y, and Shimizu T. Airway responsiveness in transgenic mice overexpressing platelet-activating factor receptor. Roles of thromboxanes and leukotrienes. Am J Respir Crit Care Med 156: 1621-1627, 1997.
32. Negro JM, Miralles JC, Ortiz JL, Funes E, and Garcia A. Leukotrienes and their antagonists in allergic disorders. Allergol Immunopathol 25: 104-112, 1997.
33. Park TS and Gidday JM. Platelet-activating factor mediates ischemia-induced leukocyte-endothelial adherence in newborn pig brain. J Cereb Blood Flow Metab 19: 417-424, 1999.
34. Prescott SM, Zimmerman GA, Stafforini DM, and McIntyre TM. Platelet-activating factor and related lipid mediators. Annu Rev Biochem 69: 419-445, 2000.
35. Salas A, Panes J, Elizalde JI, Granger DN, and Pique JM. Reperfusion-induced oxidative stress in diabetes: cellular and enzymatic sources. J Leukoc Biol 66: 59-66, 1999.
36. Sirois MG, Jancar S, Braquet P, Plante GE, and Sirois P. PAF increases vascular permeability in selected tissues: effect of BN-52021 and L-655,240. Prostaglandins 36: 631-644, 1988.
37. 4 promotes reactive oxidant generation and leukocyte adherence during acute hypoxia. J Appl Physiol 91: 1160-1167, 2001.
38. Steiner DRS, Gonzalez NC, and Wood JG. Interaction between reactive oxygen species and nitric oxide in the microvascular response to systemic hypoxia. J Appl Physiol 93: 1411-1418, 2002.
39. Steiner DRS, Gonzalez NC, and Wood JG. Mast cells mediate the microvascular inflammatory response to systemic hypoxia. J Appl Physiol 94: 325-334, 2003.
40. Sullivan GW, Sarembock IJ, and Linden J. The role of inflammation in vascular diseases. J Leukoc Biol 67: 591-602, 2000.
41. 4 stable analogues. J Clin Invest 101: 819-826, 1998.
42. Thorlacius H, Raud J, Xie X, Hedqvist P, and Lindblom L. Microvascular mechanisms of histamine-induced potentiation of leukocyte adhesion evoked by chemoattractants. Br J Pharmacol 116: 3175-3180, 1995.
43. Valeski JE and Baldwin AL. Effect of early transient adherent leukocytes on venular permeability and endothelial actin cytoskeleton. Am J Physiol Heart Circ Physiol 277: H569-H575, 1999.
44. 4. J Appl Physiol 78: 1121-1131, 1995.
45. Walther A, Yilmaz N, Schmidt W, Bach A, Gebhard MM, Martin E, and Schmidt H. Role of platelet-activating factor in leukocyte-independent plasma extravasation and mast cell activation during endotoxemia. J Surg Res 93: 265-271, 2000.
46. Wood JG, Johnson JS, Mattioli LF, and Gonzalez NC. Systemic hypoxia increases leukocyte emigration and vascular permeability in conscious rats. J Appl Physiol 89: 1561-1567, 2000.
47. Wood JG, Johnson JS, Mattioli LF, and Gonzalez NC. Systemic hypoxia promotes leukocyte-endothelial adherence via reactive oxidant generation. J Appl Physiol 87: 1734-1740, 1999.
48. Wood JG, Mattioli LF, and Gonzalez NC. Hypoxia causes leukocyte adherence to mesenteric venules in non-acclimatized rats but not after acclimatization to hypoxia. J Appl Physiol 87: 873-881, 1999.